Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumPAC’s Role in the ACR’s Advocacy Efforts

From the College  |  March 7, 2024

This is an election year, making it critical that RheumPAC, the ACR’s non-partisan political action committee, be well positioned to support our congressional champions. Keep reading to find answers to some commonly asked questions about RheumPAC and its important role in the ACR’s advocacy efforts.

What is a political action committee?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A political action committee (PAC) is a group or legal entity formed to raise and contribute money to the campaigns of candidates it supports. PACs are highly regulated by the Federal Election Commission, and RheumPAC is required to file quarterly reports detailing all contributions and disbursements. Those reports are publicly available.

What is RheumPAC, and why do we need it?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

RheumPAC is the ACR’s nonpartisan PAC that works to elect and support pro‐rheumatology candidates. It is the only PAC dedicated to the interests of the rheumatology profession. RheumPAC was formed in 2007 and creates opportunities to educate and develop relationships with members of Congress, as well as support champions for our issues and our message. It is the financial vehicle through which ACR and ARP members can support candidates who share our commitment to rheumatology.

What makes a lawmaker an ACR congressional champion, and who receives financial support from RheumPAC?

RheumPAC is bipartisan and determines candidates’ eligibility for a contribution based on their past support for policies that directly impact rheumatology or their ability to further our goals based on their position in Congress. For example, RheumPAC-supported lawmakers may introduce or co-sponsor ACR-endorsed legislation or serve on key committees that have jurisdiction over the ACR’s priority issues.

Candidates are recommended for support by ACR/ARP members and our advocacy staff. The RheumPAC committee reviews these recommendations and has final approval of the list of supported candidates. All U.S. ACR and ARP members are welcome to suggest candidates for support.

What issues does RheumPAC focus on?

RheumPAC focuses on the ACR’s top public policy priorities, which are set by the Government Affairs Committee and approved by the Board of Directors. These priorities are closely aligned with the problems you face in your practice, such as inadequate Medicare reimbursement and policies that increase administrative burden for practices. For more information, check out the ACR’s 2024 Policy Priorities.  

Who can contribute to RheumPAC?

U.S. citizens or permanent resident aliens who are members of the ACR or the ARP may invest in RheumPAC here.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:ACR advocacyRheumPAC

Related Articles

    PAC a Punch on Capitol Hill

    May 1, 2007

    New political action committee will be a voice for rheumatology

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences